(Q67898257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Comparison of Effects of Transforming Growth Factor-Beta and Cyclosporin A on Antigen-Presenting Cells of Blood and Epidermis (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

3 December 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826121

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

3 December 2022

author name string

A. Demidem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826121

3 December 2022

J. R. Taylor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826121

3 December 2022

S. F. Grammer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826121

3 December 2022

J. W. Streilein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826121

3 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:S0022202X9190439W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

https://api.elsevier.com/content/article/PII:S0022202X9190439W?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Journal of Investigative Dermatology

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

401-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/1523-1747.ep12469761

18 September 2019

exact match

0 references

cites work

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

The effects of cyclosporin A on the immune system

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Cyclosporin-A inhibits IL-2 production by all human T-cell clones having this function, independent of the phenotype or the coexpression of cytolytic activity

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Sensitivity of veiled (dendritic) cells to cyclosporine

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Studies with fluorescein isothiocyanate

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Inhibition of antigen-specific activation of an L3T4+ T cell line by cyclosporine with maintenance of macrophage-mediated antigen presentation

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Cyclosporin A treatment of severe psoriasis

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Low-dose cyclosporin A in severe psoriasis. A double-blind study

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Effectiveness of cyclosporine treatment in severe psoriasis: a clinical and immunologic study

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Transforming growth factor-beta: biological function and chemical structure

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Expression and secretion of type beta transforming growth factor by activated human macrophages

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Cyclosporine affects the function of antigen-presenting cells

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Inhibition of the accessory function of murine macrophages in vitro by cyclosporine

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Macrophages as targets for inhibition by cyclosporine

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

3 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

3 December 2022

35

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products

3 December 2022

39

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Migration and maturation of Langerhans cells in skin transplants and explants

3 December 2022

40

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

3 December 2022

41

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens)

3 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761

Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes

3 December 2022

43

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469761